Literature DB >> 24085629

Echinacea purpurea root extract enhances the adipocyte differentiation of 3T3-L1 cells.

Dong-Mi Shin1, Kyeong-Mi Choi, Youn-Sun Lee, Wonkyun Kim, Kyong-Oh Shin, Seikwan Oh, Jae-Chul Jung, Mi Kyeong Lee, Yong-Moon Lee, Jin Tae Hong, Yeo-Pyo Yun, Hwan-Soo Yoo.   

Abstract

Echinacea purpurea has been shown to have anti-diabetic activities; for example, it activates peroxisome proliferator-activated receptor γ (PPARγ) and increases insulin-stimulated glucose uptake. Adipogenesis has been used to study the insulin signaling pathway and to screen anti-diabetic compounds. The present study was conducted to investigate the effects of an ethanol extract of E. purpurea (EEEP) and its constituents on the insulin-induced adipocyte differentiation of 3T3-L1 preadipocytes. When adipocyte differentiation was induced with insulin plus 3-isobutyl-1-methylxanthine and dexamethasone, the accumulation of lipid droplets and the cellular triglyceride content were significantly increased by EEEP. The expressions of PPARγ and C/EBPα in adipocytes treated with EEEP were gradually increased as compared with control cells. Fat accumulation and triglyceride content of adipocytes treated with dodeca-2(E),4(E)-dienoic acid isobutylamide were significantly increased as compared with control cells. The expressions of PPARγ and C/EBPα in adipocytes treated with dodeca-2(E),4(E)-dienoic acid isobutylamide were significantly higher than in control cells. These results suggest EEEP promotes the adipogenesis that is partially induced by insulin and that dodeca-2(E),4(E)-dienoic acid isobutylamide appears to be responsible for EEEP-enhanced adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24085629     DOI: 10.1007/s12272-013-0251-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  5 in total

1.  Dodeca-2(E),4(E)-dienoic acid isobutylamide enhances glucose uptake in 3T3-L1 cells via activation of Akt signaling.

Authors:  Kyeong-Mi Choi; Wonkyun Kim; Jin Tae Hong; Hwan-Soo Yoo
Journal:  Mol Cell Biochem       Date:  2016-11-16       Impact factor: 3.396

2.  The Alkamide trans-Pellitorine Targets PPARγ via TRPV1 and TRPA1 to Reduce Lipid Accumulation in Developing 3T3-L1 Adipocytes.

Authors:  Barbara Lieder; Mathias Zaunschirm; Ann-Katrin Holik; Jakob P Ley; Joachim Hans; Gerhard E Krammer; Veronika Somoza
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

Review 3.  Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019.

Authors:  M F Nagoor Meeran; Hayate Javed; Charu Sharma; Sameer N Goyal; Sanjay Kumar; Niraj Kumar Jha; Shreesh Ojha
Journal:  Heliyon       Date:  2021-02-08

Review 4.  Echinacea biotechnology: advances, commercialization and future considerations.

Authors:  Jessica L Parsons; Stewart I Cameron; Cory S Harris; Myron L Smith
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

5.  Simultaneous Determination of Seven Phenolic Acids in Rat Plasma Using UHPLC-ESI-MS/MS after Oral Administration of Echinacea purpurea Extract.

Authors:  Yan Du; Zhibin Wang; Libo Wang; Mingjie Gao; Liqian Wang; Chunli Gan; Chunjuan Yang
Journal:  Molecules       Date:  2017-09-07       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.